Sopharma AD (WSE:SPH)
12.75
-0.25 (-1.92%)
Sep 16, 2025, 6:57 PM CET
Sopharma AD Revenue
Sopharma AD had revenue of 637.01M BGN in the quarter ending June 30, 2025, with 28.75% growth. This brings the company's revenue in the last twelve months to 2.41B, up 22.15% year-over-year. In the year 2024, Sopharma AD had annual revenue of 2.14B with 13.27% growth.
Revenue (ttm)
2.41B BGN
Revenue Growth
+22.15%
P/S Ratio
0.56
Revenue / Employee
430.85K BGN
Employees
5,599
Market Cap
2.94B PLN
Revenue Chart
* This company reports financials in BGN.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.14B | 250.64M | 13.27% |
Dec 31, 2023 | 1.89B | 217.31M | 13.00% |
Dec 31, 2022 | 1.67B | 60.17M | 3.73% |
Dec 31, 2021 | 1.61B | 165.21M | 11.42% |
Dec 31, 2020 | 1.45B | 158.02M | 12.27% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Diagnostyka | 2.17B |
NEUCA | 13.04B |
Synektik Spólka Akcyjna | 623.20M |
Voxel | 560.38M |
Celon Pharma | 215.11M |
Ryvu Therapeutics | 97.57M |
Selvita | 359.79M |
Centrum Medyczne ENEL-MED | 762.83M |